105
Views
32
CrossRef citations to date
0
Altmetric
Original Research

Chitosan nanoparticle-based delivery of fused NKG2D–IL-21 gene suppresses colon cancer growth in mice

, , , , , , & show all
Pages 3095-3107 | Published online: 13 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ghazale Faraji, Pedram Moeini, Ali Rajabi Torkamani, Haniye Shafiee & Ehsan Nazemalhosseini Mojarad. (2023) Nano-particles’ benefits for colon cancer effective therapy: a review of recent advancements and clinical trials. International Journal of Polymeric Materials and Polymeric Biomaterials 0:0, pages 1-16.
Read now
Xinxin Liu, Dandan Shi, Lu Guo, Xiaoying Zhou, Mengmeng Shang, Xiao Sun, Dong Meng, Yading Zhao & Jie Li. (2021) Echogenic, Ultrasound-Sensitive Chitosan Nanodroplets for Spatiotemporally Controlled DKK-2 Gene Delivery to Prostate Cancer Cells. International Journal of Nanomedicine 16, pages 421-432.
Read now
Yi Qiu, Mengxi Su, Leyi Liu, Yiqi Tang, Yuan Pan & Jianbo Sun. (2021) Clinical Application of Cytokines in Cancer Immunotherapy. Drug Design, Development and Therapy 15, pages 2269-2287.
Read now

Articles from other publishers (29)

Shuai Guo, Jie Feng, Zongheng Li, Sugeun Yang, Xiaozhong Qiu, Yikai Xu & Zheyu Shen. (2022) Improved cancer immunotherapy strategies by nanomedicine. WIREs Nanomedicine and Nanobiotechnology 15:3.
Crossref
Aun Raza, Gustavo Rodrigues Rossi, Taskeen Iqbal Janjua, Fernando Souza-Fonseca-Guimaraes & Amirali Popat. (2023) Nanobiomaterials to modulate natural killer cell responses for effective cancer immunotherapy. Trends in Biotechnology 41:1, pages 77-92.
Crossref
Mengsi Zhan, Yunqi Guo, Mingwu Shen & Xiangyang Shi. (2022) Nanomaterial‐Boosted Tumor Immunotherapy Through Natural Killer Cells. Advanced NanoBiomed Research 2:12, pages 2200096.
Crossref
Heping Lian, Shuang Ma, Duoyi Zhao, Wei Zhao, Yan Cui, Yingqi Hua & Zhiyu Zhang. (2022) Cytokine Therapy Combined with Nanomaterials Participates in Cancer Immunotherapy. Pharmaceutics 14:12, pages 2606.
Crossref
Dhanashree Murugan, Vasanth Murugesan, Balaji Panchapakesan & Loganathan Rangasamy. (2022) Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy. Cancers 14:21, pages 5438.
Crossref
Tao Ming Sim. (2022) Nanoparticle-assisted targeting of the tumour microenvironment. OpenNano 8, pages 100097.
Crossref
Saji Uthaman, Gabriel Cutshaw, Saman Ghazvini & Rizia Bardhan. (2022) Nanomaterials for Natural Killer Cell-Based Immunoimaging and Immunotherapies in Cancer. ACS Applied Materials & Interfaces.
Crossref
Eimear Mylod, Joanne Lysaght & Melissa J. Conroy. (2022) Natural killer cell therapy: A new frontier for obesity-associated cancer. Cancer Letters 535, pages 215620.
Crossref
I. V. Alekseenko, V. V. Pleshkan, A. I. Kuzmich, S. A. Kondratieva & E. D. Sverdlov. (2022) Gene-Immune Therapy of Cancer: Approaches and Problems. Russian Journal of Genetics 58:5, pages 491-506.
Crossref
Jhalak Dholakia, Alexander C. Cohen, Charles A. LeathIIIIII, Elizabeth T. Evans, Ronald D. Alvarez & Premal H. Thaker. (2022) Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications. Current Oncology Reports 24:4, pages 389-397.
Crossref
Kai Li, Zhicheng Zhang, Yu Mei, Mengmeng Li, Qingzhu Yang, Qiong Wu, Huanjie Yang, Liangcan He & Shaoqin Liu. (2022) Targeting the innate immune system with nanoparticles for cancer immunotherapy. Journal of Materials Chemistry B 10:11, pages 1709-1733.
Crossref
Yanfeng Zhou, Chang Liu & Haiyun Song. (2022) Innate Immunomodulatory Nanodevices for Cancer Therapy: A Review. Journal of Biomedical Nanotechnology 18:2, pages 293-318.
Crossref
Carmen Campos-Silva, Silvia López-Borrego, María José Felgueres, Gloria Esteso & Mar Vales-Gomez. (2022) NKG2D Ligands in Liquid Biopsy: The Importance of Soluble and Vesicle-Bound Proteins for Immune Modulation. Critical Reviews in Immunology 42:1, pages 21-40.
Crossref
Idoia Mikelez-Alonso, Susana Magadán, África González-Fernández & Francisco Borrego. (2021) Natural killer (NK) cell-based immunotherapies and the many faces of NK cell memory: A look into how nanoparticles enhance NK cell activity. Advanced Drug Delivery Reviews 176, pages 113860.
Crossref
Beatriz V. Lima, Maria J. Oliveira, Mário A. Barbosa, Raquel M. Gonçalves & Flávia Castro. (2021) Immunomodulatory potential of chitosan-based materials for cancer therapy: a systematic review of in vitro , in vivo and clinical studies . Biomaterials Science 9:9, pages 3209-3227.
Crossref
Kwang-Soo Kim, Dong-Hwan Kim & Dong-Hyun Kim. (2021) Recent Advances to Augment NK Cell Cancer Immunotherapy Using Nanoparticles. Pharmaceutics 13:4, pages 525.
Crossref
J.F.A. Valente, P. Pereira, A. Sousa, J.A. Queiroz & F. Sousa. (2021) Effect of Plasmid DNA Size on Chitosan or Polyethyleneimine Polyplexes Formulation. Polymers 13:5, pages 793.
Crossref
Neelam Thakur, Saloni Thakur, Sharmistha Chatterjee, Joydeep Das & Parames C. Sil. (2020) Nanoparticles as Smart Carriers for Enhanced Cancer Immunotherapy. Frontiers in Chemistry 8.
Crossref
Fateme Ghorbani, Parviz Kokhaei, Majid Ghorbani & Majid Eslami. (2020) Application of different nanoparticles in the diagnosis of colorectal cancer. Gene Reports 21, pages 100896.
Crossref
Rohitas Deshmukh. (2020) Bridging the Gap of Drug Delivery in Colon Cancer: The Role of Chitosan and Pectin Based Nanocarriers System. Current Drug Delivery 17:10, pages 911-924.
Crossref
Hamed Barabadi, Hossein Vahidi, Kaveh Damavandi Kamali, Masoumeh Rashedi, Omid Hosseini, Ahmad Reza Golnaraghi Ghomi & Muthupandian Saravanan. (2019) Emerging Theranostic Silver Nanomaterials to Combat Colorectal Cancer: A Systematic Review. Journal of Cluster Science 31:2, pages 311-321.
Crossref
Cao Dai Phung, Tuan Hiep Tran & Jong Oh Kim. (2020) Engineered nanoparticles to enhance natural killer cell activity towards onco-immunotherapy: a review. Archives of Pharmacal Research 43:1, pages 32-45.
Crossref
Riccardo Rampado, Sara Crotti, Paolo Caliceti, Salvatore Pucciarelli & Marco Agostini. (2019) Nanovectors Design for Theranostic Applications in Colorectal Cancer. Journal of Oncology 2019, pages 1-27.
Crossref
Ana I. Matos, Barbara Carreira, Carina Peres, Liane I.F. Moura, João Conniot, Thibaut Fourniols, Anna Scomparin, Águeda Martínez-Barriocanal, Diego Arango, João P. Conde, Véronique Préat, Ronit Satchi-Fainaro & Helena F. Florindo. (2019) Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer. Journal of Controlled Release 307, pages 108-138.
Crossref
Guimiao Lin, Li Li, Nishtha Panwar, Jie Wang, Swee Chuan Tjin, Xiaomei Wang & Ken-Tye Yong. (2018) Non-viral gene therapy using multifunctional nanoparticles: Status, challenges, and opportunities. Coordination Chemistry Reviews 374, pages 133-152.
Crossref
Dominik Schmiedel & Ofer Mandelboim. (2018) NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy. Frontiers in Immunology 9.
Crossref
Gayathri Kandasamy, Vadim Annenkov & Uma Maheswari Krishnan. (2018) Nanoimmunotherapy – cloaked defenders to breach the cancer fortress. Nanotechnology Reviews 7:4, pages 317-340.
Crossref
Hui Ding, Xi Yang & Yanzhang Wei. (2018) Fusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy. International Journal of Molecular Sciences 19:1, pages 177.
Crossref
Lacy E. Lowry & William A. Zehring. (2017) Potentiation of Natural Killer Cells for Cancer Immunotherapy: A Review of Literature. Frontiers in Immunology 8.
Crossref